146 related articles for article (PubMed ID: 8269186)
1. Angiographic restenosis after angioplasty: comparison of definitions and correlation with clinical outcome.
Gershlick A; Brack MJ; More RS; Syndercombe-Court D; Balcon R
Coron Artery Dis; 1993 Jan; 4(1):73-81. PubMed ID: 8269186
[TBL] [Abstract][Full Text] [Related]
2. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
[TBL] [Abstract][Full Text] [Related]
3. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
[TBL] [Abstract][Full Text] [Related]
4. Luminal narrowing after percutaneous transluminal coronary angioplasty. A multivariate analysis of clinical, procedural and lesion related factors affecting long-term angiographic outcome in the PARK study. Post-Angioplasty Restenosis Ketanserin.
Melkert R; Violaris AG; Serruys PW
J Invasive Cardiol; 1994 Jun; 6(5):160-71. PubMed ID: 10155065
[TBL] [Abstract][Full Text] [Related]
5. [Coronary restenosis: the cardiologist facing problems of definitions].
Charron P; Montalescot G; Drobinski G; Grosgogeat Y; Thomas D
Arch Mal Coeur Vaiss; 1995 Jan; 88(1):13-9. PubMed ID: 7646244
[TBL] [Abstract][Full Text] [Related]
6. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
[TBL] [Abstract][Full Text] [Related]
7. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
[TBL] [Abstract][Full Text] [Related]
8. Detection of angiographic coronary restenosis after percutaneous transluminal coronary angioplasty (PTCA): usefulness of angina combined with rest electrocardiogram.
Gottschall CA; Miler V; Castro I; Rodrigues R
J Invasive Cardiol; 1999 Jul; 11(7):403-9. PubMed ID: 10745562
[TBL] [Abstract][Full Text] [Related]
9. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
Foley DP; Melkert R; Serruys PW
Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
[TBL] [Abstract][Full Text] [Related]
10. [Clinical prognosis of moderate restenosis after percutaneous transluminal coronary angioplasty].
Fukuzawa S; Ozawa S; Katagiri M; Watanabe H
J Cardiol; 1995 Feb; 25(2):63-8. PubMed ID: 7897608
[TBL] [Abstract][Full Text] [Related]
11. Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) Study.
Jørgensen B; Thaulow E;
Am Heart J; 2003 Jun; 145(6):1030-5. PubMed ID: 12796759
[TBL] [Abstract][Full Text] [Related]
12. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.
Rensing BJ; Hermans WR; Vos J; Tijssen JG; Rutch W; Danchin N; Heyndrickx GR; Mast EG; Wijns W; Serruys PW
Circulation; 1993 Sep; 88(3):975-85. PubMed ID: 8353925
[TBL] [Abstract][Full Text] [Related]
13. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.
Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M
Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between morphology of restenosis and clinical aspects in patients who had undergone coronary angioplasty].
Bramucci E; de Servi S; Ghio S; Cioffi P; Angoli L; Barberis P; Ferrario M; Poma E; Ardissino D; Montemartini C
G Ital Cardiol; 1988 Oct; 18(10):819-23. PubMed ID: 2977595
[TBL] [Abstract][Full Text] [Related]
15. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Circulation; 1992 Jul; 86(1):100-10. PubMed ID: 1535568
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of PAI-1 plasma activity and thallium perfusion imaging for restenosis after percutaneous transluminal angioplasty in clinically asymptomatic patients.
Gottsauner-Wolf M; Sochor H; Hornykewycz S; Beckmann R; Lang I; Probst P; Binder BR; Huber K
Thromb Haemost; 1999 Apr; 81(4):522-6. PubMed ID: 10235432
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and angiographic course after coronary angioplasty. Analysis of predictor factors of restenosis].
Sanz E; Domingo E; Moreno V; Angel J; Anivarro I; Alió J; Alijarde M; Soler-Soler J
Rev Esp Cardiol; 1992 Nov; 45(9):568-77. PubMed ID: 1475495
[TBL] [Abstract][Full Text] [Related]
18. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica.
Maresta A; Balducelli M; Cantini L; Casari A; Chioin R; Fabbri M; Fontanelli A; Monici Preti PA; Repetto S; De Servi S
Circulation; 1994 Dec; 90(6):2710-5. PubMed ID: 7994812
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiographic and hemodynamic results of coronary balloon angioplasty on late angiographic outcome.
Liu MW; Roubin GS; King SB
Am Heart J; 1994 Dec; 128(6 Pt 1):1077-83. PubMed ID: 7985587
[TBL] [Abstract][Full Text] [Related]
20. Prevention of coronary arterial renarrowing by continuous 3-day infusion of tissue plasminogen activator after successful percutaneous transluminal coronary angioplasty: a randomized, double-blind, placebo-controlled study.
Kanamasa K; Ogawa I; Hayashi T; Nakabayashi T; Otani N; Ishikawa K
Angiology; 2000 May; 51(5):367-75. PubMed ID: 10826853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
